Management Advisory Council
The BHCRI Management Advisory Council is composed of:
3 members from discovery/experimental research
3 members from clinical/translational research
2 members from population health research
2 members from behavioural research (to be interpreted broadly)
2 members from locally active supporting organizations
2 members from nationally active supporting organizations
4 members from the lay/business community
with significant representation of all four Atlantic Provinces
Members of the BHCRI Management Advisory Council:
- Dr. Stephen Lewis, Chair, Assistant Scientific Director, Atlantic Cancer Research Institute, Moncton, NB
Dr. Stephen M. Lewis received his Ph.D. from Dalhousie University in 2004, where he studied the molecular mechanisms of vesicle trafficking in the budding yeast Saccharomyces cerevisiae. From 2004 until 2007, he pursued postdoctoral training in the molecular biology of translational control at the Apoptosis Research Centre, located at the University of Ottawa. Dr. Lewis joined the Atlantic Cancer Research Institute in 2008 as a Research Scientist and has been the Assistant Scientific Director since 2013. At ACRI he oversees projects on the use of extracellular vesicles for cancer detection and therapeutics, as well as projects focused on the identification of novel therapeutic targets for cancer. Dr. Lewis’s independent research program is investigating how deregulated protein synthesis contributes to the development and progression of cancer, with a particular emphasis on metastatic breast cancer.
- Ms. Erika Nicholson, Vice-Chair; Director, Screening and Early Detection, Canadian Partnership Against Cancer
Erika is the Director, Screening and Early Detection with the Canadian Partnership Against Cancer – an independent organization funded by the federal government to accelerate action on cancer control for all Canadians. Prior to joining the Partnership, Erika was Senior Director for the Nova Scotia Cancer Care Program, Nova Scotia Health Authority, and was responsible for the overall transformation and management of cancer care services in the province. She has more than a decade of strategic leadership experience in cancer control in Nova Scotia – establishing herself as a driver of system change built on a solid foundation of stakeholder engagement and moving evidence into practice. Erika holds a Bachelor of Science in Nutritional Science and a Masters of Health Science in Community Health, both from the University of Toronto.
- Mr. Bill Bean, President and CEO, QEII Foundation, Halifax, NS
- Dr. Sheila Drover, Associate Professor of Immunology, Division of BioMedical Sciences, Memorial University of Newfoundland, St. John’s, NL
Dr. Drover is an Associate Professor of Immunology whose main research interest is in understanding the role of immune system in cancer and its application to immunotherapy. Current research activities include investigating the mechanism of dysregulated immune pathways in HER2-positive breast cancer and modulation of immune activation, immune inhibitory molecules on cancer cell lines using small kinase inhibitors and targeted immune therapeutics. Dr. Drover’s research program has been funded by Medical Research Foundation Awards at Memorial University, Canadian Breast Cancer Research Alliance, CIHR and RDC, and Canadian Breast Cancer Foundation (Atlantic Chapter). She has served on several grants panels including NCIC/CBCRA, Faculty of Medicine (Memorial University) Research and Development, CBCF (Atlantic and Ontario) and CIHR.
- Dr. Conrad Fernandez, Pediatric Hematologist/Oncologist, Departments of Pediatrics and Bioethics, IWK Health Centre, Halifax, NS
Dr. Conrad Fernandez is a professor and head of the Division of Pediatric Hematology/Oncology in the Department of Pediatrics, IWK Health Centre, Dalhousie University. He is cross-appointed in the Departments of Bioethics. He is vice-Chair of the Children’s Oncology Group (COG) Bioethics committee and co-Chair of the newly established COG Return of Research Results committee. He has an active research program in the return of research results to participants. He is also a member of the COG renal tumors steering committee and conducts clinical trials in childhood kidney cancer.
- Dr. Roger Gervais, Retired VP Research, New Brunswick Innovation Foundation, Fredericton, NB
Dr. Gervais is a career administrator with a PhD in Education Administration and is responsible for various management, planning and evaluation activities in several organizations. He has experience in multi-million dollar budget management, including the financial processes related to them. As a manager and researcher, he secured the necessary funding to implement several large-scale R&D projects. As president of Enterprises NRG, he has undertaken several evaluation studies. He also wrote several confidential reports for New Brunswick institutions and organizations leading to the implementation of new programs or initiatives.
- Dr. Laura Gillespie, Professor of Molecular Oncology, Division of BioMedical Sciences, Memorial University of Newfoundland
Dr. Laura Gillespie is a professor and founding member of the Terry Fox Cancer Research Laboratories in the Faculty of Medicine at Memorial University. She runs an active breast cancer research program, focusing on gene regulators and their role in tumour suppression during breast cancer initiation and progression. She has served on grants panels from a variety of federalagencies and private charities, including the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC), the Canadian Research Society (CRS), the Breast Cancer Society (BCS)and the Canadian Breast Cancer Foundation (CBCF). Throughout her career, her research work has been supported by funds from the CIHR, NSERC, CBCF,CRS, BCS, the Canadian Cancer Society Research Institute and the Biotechnology sector. She holds a patent for her gene discovery and is actively engaged in community outreach programs, particularly in the area of breast cancer education.
- Dr. David Hoskin, Professor of Pathology, Microbiology and Immunology, and Surgery, Dalhousie University
Dr. David Hoskin is a professor of Pathology, Microbiology and Immunology, and Surgery at Dalhousie University. He also holds the Canadian Breast Cancer Foundation-Atlantic Region endowed chair in breast cancer research. In addition to his academic appointments, Dr. Hoskin is a member of the Canadian Breast Cancer Foundation's board of directors and is chair of the Canadian Breast Cancer Foundation national grants committee. Dr. Hoskin has also served on numerous scientific review panels and is a member of the editorial board of cancer letters. Dr. Hoskin's research interests include iron metabolism by breast cancer cells and breast cancer prevention and treatment using natural products. His research program is supported by agencies such as the Natural Sciences and Engineering Research Council of Canada, the Breast Cancer Society of Canada, and the Canadian Breast Cancer Foundation. Dr. Hoskin has published over 150 peer-reviewed research articles and book chapters.
- Dr. Sara Kirk, Scientific Director, Healthy Populations Institute, Dalhousie University, Halifax, NS
- Dr. Eshwar Kumar, Co-CEO, New Brunswick Cancer Network, Fredericton, NB
Dr. Eshwar Kumar has been Co-CEO of the New Brunswick Cancer Network, a division of the New Brunswick Department of Health since 2005. A graduate of St Johns Medical College at Bangalore University, India, he obtained his Fellowship in Radiotherapy and Oncology from the Royal College of Radiologists, London, UK in 1982. He has been practicing as a Radiation Oncologist in Saint John, New Brunswick since 1984. He was Head of the Department of Oncology and Medical Director of the Oncology Program at the Atlantic Health Sciences Corporation, Saint John, NB, from June 1994 to March 2009. He is an Assistant Professor in the Department of Radiation Oncology at Dalhousie University, Halifax. He is currently on the Board of Directors of the Canadian Association of Provincial Cancer Agencies (CAPCA) as well as the Board of directors of the Canadian Partnership Against Cancer (CPAC) and the Canadian Cancer Society -NB Division. He also serves as a surveyor for Accreditation Canada.
- Mr. Chris MacDougall, Businessman, Truro, Nova Scotia
Chris MacDougall, a former Truro lawyer, is the owner and operator of a Tim Horton’s Restaurant in Elmsdale, Nova Scotia. He received a Degree in Business Administration from Acadia University in 1976 and in 1980, he obtained a Degree in Law from Dalhousie University. Chris currently lives in Truro and has been very active in community affairs, having recently chaired a $26 million fundraising campaign for a new Regional Hospital.
- Mr. Rod MacLennan, Retired Businessman, Truro, Nova Scotia
- Dr. Anthony Reiman, Canadian Cancer Society Research Chair, University of New Brunswick; Medical Oncologist, Saint John Regional Hospital; Assistant Dean, Research, Dalhousie Medicine New Brunswick
Dr. Reiman is a medical oncologist at the Saint John Regional Hospital, where he provides front line cancer care including diagnosis, systemic therapy and opportunities for patients to participate in research protocols. He is the Canadian Cancer Society Research Chair at the University of New Brunswick, with a focus on novel therapies and biomarkers for multiple myeloma, lymphoma and lung cancer. As Professor of Medicine and Assistant Dean, Research for the Dalhousie Medicine New Brunswick program, Dr. Reiman has helped to build and maintain a new research program in New Brunswick including cardiovascular research, occupational medicine and oncology and the provision of research opportunities to medical students, undergraduates, residents and postdoctoral fellows. Dr. Reiman serves on the board of directors of the New Brunswick Health Research Foundation and the scientific advisory boards of Myeloma Canada and Lymphoma Canada. He is on several committees of the NCIC Clinical Trials Group and is a member of the US NCI Myeloma Steering Committee and the International Myeloma Working Group. Dr. Reiman has published over 180 peer reviewed cancer research manuscripts and presentations.
- Ms. Heather Strong, former Provincial Director, The Terry Fox Foundation, St. John's, NL
Heather Strong is the former Terry Fox Foundation’s Provincial Director in Newfoundland & Labrador. Heather’s profession afforded her the opportunity to combine her two passions - funding cancer research and celebrating the legacy of a Canadian hero. Having been responsible for the oversight of hundreds of annual cancer research fundraising events hosted exclusively by passionate and dedicated volunteers, Heather has extensive experience. In her spare time, Heather is a national caliber curler who has represented her province at the Canadian Women’s Curling Championships on several occasions over the last two decades.
- Ms. Kaye Folland, Interim Co-CEO, Dalhousie Medical Research Foundation, Halifax, NS
- Mr. Daniel Tweel, Lawyer, Tweel Law, Charlottetown, PE
Danny is a lawyer in private practice in Charlottetown. He holds an honours degree in law from Leeds University, England, is a member of the PEI Law Society and the Canadian Bar Association and has appeared before numerous boards, tribunals and the three levels of Court in the province. He has held positions on numerous boards including the National Trust where he represented Prince Edward Island for several years. He has been involved with BHCRI since 2012 and has served on various committees. Danny is an avid photographer and enjoys restoring and driving classic British cars. He is an active participant and restorer of built heritage in downtown Charlottetown.
- Dr. Robin Urquhart, Assistant Professor, Department of Surgery, Dalhousie University, Halifax, NS
Dr. Robin Urquhart is an Assistant Professor and Ramia Scientist in the Department of Surgery at Dalhousie University, with cross-appointments in the Department of Community Health and Epidemiology and Division of Medical Education. She is also an Affiliate Scientist at the Nova Scotia Health Authority. Her research relates to understanding how scientific evidence moves into clinical practice and policy for persons diagnosed with cancer, and which strategies optimize its implementation, scale-up, and sustained use. The goal of her research is to increase the use of scientific evidence across settings so that important discoveries reach more people, more quickly, and in a more lasting way. Robin’s contributions to health research and health care have been recognized by numerous awards, including the 2014 Discovery Award for Science and Technology (Emerging Professional category).
- Ms. Elaine Warren, President, Association of Registered Nurses of NL, St. John's, NL